Three targets of branched-chain amino acid supplementation in the treatment of liver disease
Three targets of branched-chain amino acid supplementation in the treatment of liver disease
About this item
Full title
Author / Creator
Publisher
New York, NY: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
The article explains the pathogenesis of disturbances in branched-chain amino acid (BCAA; valine, leucine, and isoleucine) and protein metabolism in various forms of hepatic injury and it is suggested that the main cause of decrease in plasma BCAA concentration in liver cirrhosis is hyperammonemia. Three possible targets of BCAA supplementation in...
Alternative Titles
Full title
Three targets of branched-chain amino acid supplementation in the treatment of liver disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_733456413
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733456413
Other Identifiers
ISSN
0899-9007
E-ISSN
1873-1244
DOI
10.1016/j.nut.2009.06.027
